Apoptosis Market Analysis: By Mechanism (Molecular Pathways, Caspase Activators and Inhibitors, Protease/Proteasome Inhibitors, Bcl-2 Modulators, p53 Modulators); By Drug Class and By Type of Disease Treatment With Forecast (2016-2021)

  • ID: 3919960
  • Report
  • 149 pages
  • IndustryARC
1 of 3
Programmed self destruction of damaged or abnormal cells is termed as apoptosis. When cells in multicellular organism are no longer required, intracellular destrcuction of the cells begins. However, excessive and insufficient apoptotic processes have been known to be associated with several diseases. While excessive apoptosis is attributed to atrophy, an insuffienct apoptosis can result in an uncontrolled proliferation of unwanted cells and can result in cancer. There are several other diseases such as neurodegenerative diseases such as Alzeihmer’s, Huntinton’s and ALS and other autoimmune diseases that are stem from either a failure of apoptosis in elimination of harmful cells or unwanted activation of apoptosis that can result in destruction of important cells. Several drugs available in the market and those currently being research exhibit apoptosis modulating properties.

Rising number of cancer detected patients across the globe is one of the main drivers for the apoptosis market. Research and development efforts by companies as well as universities, sometimes in collaboration, is another factor augmenting the growth of this market. Lack of awareness is one factor that can potentially restrain the growth of this market.

An important section on patent analysis is included in this report that explores some of the most influential patents and potential indications for apoptosis modulation.?Apoptosis Market

The Apoptosis market can be segmented on the basis of mechanism as:
Bcl-2 Modulators
Caspase Activators and Inhibitors
p53 Modulators
Protease/Proteasome Inhibitors
Molecular Pathways
Others.

The Apoptosis market has also been segmented on the basis of the class of drugs as:
Direct apoptogens
First generation indirect apoptogens
second generation indirect apoptogens
reagents and kits

One of the main application of apoptosis is for the treatment of cancer.
In terms of type of disease treatment, the Apoptosis market has been segmented across the following diseases:
Cancer
Neurodegenerative diseases
Cardiovascular Diseases
Others

North America currenlty accounts for the largest share of the global apoptosis market with Europe coming a close second. The market in emerging and developing economies in APAC and South America are expected to grow at higher rates comparatively till the end of the forecast period.

The market has been segmented based on the following geographies:
North America
South America
APAC
Europe
Middle East
Africa

Following are just a few of the companies that are operating in the Apoptosis market:
Pfizer
Novartis
Amgen Inc
Abbott Laboratories
Aegera Therapeutics Inc
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Apoptosis - Market Overview
2. Executive Summary
3. Apoptosis - Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End User Profiling
3.2.3. Top 5 Financials Analysis
4. Apoptosis - Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Apoptosis Market
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition
5. Apoptosis Market - Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors
6. Apoptosis Market - By Mechanism:
6.1. Bcl-2 Modulators
6.2. Caspase Activators and Inhibitors

6.3. p53 Modulators
6.4. Molecular Pathways
6.5. Protease/Proteasome Inhibitors
6.6. Others
7. Apoptosis Market - By Drug Class:
7.1. Direct Apoptogens
7.2. First Generation Indirect Apoptogens
7.3. Second Generation Indirect Apoptogens
7.4. Reagents and Kits
8. Apoptosis Market - By Type of Disease Treatment:
8.1. Neurodegenerative Diseases
8.2. Cardiovascular Diseases
8.3. Cancer
8.4. Others
9. Apoptosis Market - By Geography:
9.1. Introduction
9.2. Global Study
9.3. Americas
9.3.1. North America
9.3.2. Brazil
9.3.3. Argentina
9.3.4. Others
9.4. Europe
9.4.1. U.K.
9.4.2. France
9.4.3. Germany
9.4.4. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. Others
9.6. ROW
10. Apoptosis Market - Market Entropy
10.1. New Product Launches
10.2. M&As, Collaborations, JVs and Partnerships
11. Company Profiles
11.1. Abbott Laboratories Inc.
11.2. Zentaris GmbH
11.3. Novartis
11.4. AbGenomics International Inc.
11.5. Aegera Therapeutics Inc.
11.6. ApopLogic Pharmaceuticals Inc.
11.7. Infinity Pharmaceuticals Inc.
11.8. Genta Inc.
11.9. Anavex Life Sciences Corporation
11.10. Chromo Therapeutics Limited
11.11. Amgen Inc.
11.12. EntreMed Inc.
11.13. Pfizer Inc.

"*Financials would be provided on a best efforts basis for private companies"
12. Appendix
12.1. Abbreviations
12.2. Sources
12.3. Research Methodology
12.4. Bibliography
12.5. Compilation of Expert Insights
12.6. Disclaimer
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll